Chairman & CEO of Edwards Lifesciences Corp (30-Year Financial, Insider Trades) Michael A Mussallem (insider trades) sold 22,850 shares of EW on 05/08/2020 at an average price of $219.58 a share. The total sale was $5 million.
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $45 billion; its shares were traded at around $217.84 with a P/E ratio of 41.65 and P/S ratio of 10.31. Edwards Lifesciences Corp had annual average EBITDA growth of 16.30% over the past ten years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 3-star. GuruFocus has detected 1 severe warning sign with Edwards Lifesciences Corp. .
CEO Recent Trades:
- Chairman & CEO Michael A Mussallem sold 22,850 shares of EW stock on 05/08/2020 at the average price of $219.58. The price of the stock has decreased by 0.79% since.
Directors and Officers Recent Trades:
- CVP,Strategy/Corp Development Donald E Jr Bobo sold 5,372 shares of EW stock on 05/08/2020 at the average price of $220.94. The price of the stock has decreased by 1.4% since.
- CVP, TAVR Larry L Wood sold 3,566 shares of EW stock on 05/01/2020 at the average price of $215. The price of the stock has increased by 1.32% since.
- CVP, EMEA, Canada, Latin Amer Jean-luc M Lemercier sold 3,470 shares of EW stock on 04/27/2020 at the average price of $223.5. The price of the stock has decreased by 2.53% since.
- CVP, Critical Care Catherine M. Szyman sold 1,116 shares of EW stock on 04/16/2020 at the average price of $216.91. The price of the stock has increased by 0.43% since.
- CVP, Japan & Intercontinental Huimin Wang sold 3,911 shares of EW stock on 04/13/2020 at the average price of $212.99. The price of the stock has increased by 2.28% since.
For the complete insider trading history of EW, click here
.
